{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "EBV",
      "HSV",
      "PAISs",
      "SARS-CoV-2",
      "astrocytes",
      "autoimmunity",
      "blood-brain-barrier",
      "cognitive impairment",
      "hippocampal neurogenesis",
      "long COVID",
      "microglia",
      "microvascular disease",
      "myelin",
      "post-acute infection syndromes"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36288726",
  "DateCompleted": {
    "Year": "2022",
    "Month": "11",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "10",
        "Day": "07"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.neuron.2022.10.006",
      "S0896-6273(22)00910-2"
    ],
    "Journal": {
      "ISSN": "1097-4199",
      "JournalIssue": {
        "Volume": "110",
        "Issue": "21",
        "PubDate": {
          "Year": "2022",
          "Month": "Nov",
          "Day": "02"
        }
      },
      "Title": "Neuron",
      "ISOAbbreviation": "Neuron"
    },
    "ArticleTitle": "The neurobiology of long COVID.",
    "Pagination": {
      "StartPage": "3484",
      "EndPage": "3496",
      "MedlinePgn": "3484-3496"
    },
    "Abstract": {
      "AbstractText": [
        "Persistent neurological and neuropsychiatric symptoms affect a substantial fraction of people after COVID-19 and represent a major component of the post-acute COVID-19 syndrome, also known as long COVID. Here, we review what is understood about the pathobiology of post-acute COVID-19 impact on the CNS and discuss possible neurobiological underpinnings of the cognitive symptoms affecting COVID-19 survivors. We propose the chief mechanisms that may contribute to this emerging neurological health crisis."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022 The Authors. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Neurology, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University, USA. Electronic address: mmonje@stanford.edu."
          }
        ],
        "LastName": "Monje",
        "ForeName": "Michelle",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunobiology, Yale University, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University, USA. Electronic address: akiko.iwasaki@yale.edu."
          }
        ],
        "LastName": "Iwasaki",
        "ForeName": "Akiko",
        "Initials": "A"
      }
    ],
    "GrantList": [
      {
        "GrantID": "U19 CA264504",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA258384",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DP1 NS111132",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 NS092597",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI157488",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P50 CA165962",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA263500",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1 TR001863",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Neuron",
    "NlmUniqueID": "8809320",
    "ISSNLinking": "0896-6273"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nervous System Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mental Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Post-Acute COVID-19 Syndrome"
    }
  ],
  "CoiStatement": "Declaration of interests M.M. holds equity in MapLight Therapeutics and Syncopation Life Sciences. A.I. holds equity in RIGImmune and Xanadu Bio. M.M. is on the advisory board for Neuron."
}